Patents by Inventor Allen Tingjin Yu

Allen Tingjin Yu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MODULATION OF LNC05 EXPRESSION
    Publication number: 20210290653
    Abstract: Provided herein are methods, compounds, and compositions for reducing expression of lnc05 in a cell or individual. Such methods, compounds, and compositions are useful to treat, prevent, delay, or ameliorate a cancer in an individual.
    Type: Application
    Filed: June 3, 2021
    Publication date: September 23, 2021
    Inventors: Allen Tingjin Yu, David L. Spector, Frank Rigo, Susan M. Freier, Jan Bergmann, Carmen Berasain
  • Modulation of Lnc05 expression
    Patent number: 11033570
    Abstract: Provided herein are methods, compounds, and compositions for reducing expression of Inc05 in a cell or individual. Such methods, compounds, and compositions are useful to treat, prevent, delay, or ameliorate a cancer in an individual.
    Type: Grant
    Filed: December 1, 2017
    Date of Patent: June 15, 2021
    Assignees: Cold Spring Harbor Laboratory, Ionis Pharmaceuticals, Inc.
    Inventors: Allen Tingjin Yu, David L. Spector, Frank Rigo, Susan M. Freier, Jan Bergmann, Carmen Berasain
  • MODULATION OF LNC05 EXPRESSION
    Publication number: 20190343863
    Abstract: Provided herein are methods, compounds, and compositions for reducing expression of Inc05 in a cell or individual. Such methods, compounds, and compositions are useful to treat, prevent, delay, or ameliorate a cancer in an individual.
    Type: Application
    Filed: December 1, 2017
    Publication date: November 14, 2019
    Applicants: Cold Spring Harbor Laboratory, Ionis Pharmaceuticals, Inc.
    Inventors: Allen Tingjin Yu, David L. Spector, Frank Rigo, Susan M. Freier, Jan Bermann, Carmen Berasain